<DOC>
	<DOCNO>NCT00236275</DOCNO>
	<brief_summary>Predict follow thanks image response neoadjuvant chemotherapy locally advance breast carcinoma . Hypothesis : FLT- ( 18F ) PET predictor superior FDG- ( 18F ) PET MRI</brief_summary>
	<brief_title>PET MRI Follow-up Neoadjuvant Chemotherapy Breast Cancer</brief_title>
	<detailed_description>PET/CT FDG- ( 18F ) FLT- ( 18F ) MRI perform initial staging , 3 time sequential adjuvant chemotherapy prior surgery , aim find efficient modality predict response neoadjuvant chemotherapy primary breast cancer possible lymph node metastasis . Post-surgical histology 6 month follow-up ( detect occult metastasis ) constitute standard truth determination comparison diagnostic performance .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Telbivudine</mesh_term>
	<criteria>Breast cancer schedule neoadjuvant chemotherapy follow surgery Exclusion criterion : Indicated chemotherapy without curative tumorectomies foresee ( plan ) Patient present evolutionary infectious inflammatory pathology , include inflammatory breast cancer , able source ( spring ) falsepositive result ( profit ) TEPFDG Patient course radiotherapy chemotherapy operate level thorax 4 week precede date foreseen ( plan ) examination TEP ( pose ( installation ) implantable room ( chamber ) exclude ) Diabetic wait Patient already include protocol search ( research ) Nuclear Medicine image use ionization radiation Patient give lit ( enlighten ) assent Wait among surveillance TEP MRI chemotherapy impossible ( geographical professional imperative , contraindication MRI , ex : port ( bear ) pacemaker , cochlear magnetic implant , metal foreign body cf protocol ) Of less 18 year old pregnant patient . Breast cancer stage ( stadium ) IV Biopsy already realize mammary tumor , period ( delay ) low 15 j . In case alcoholic poison antecedent reaction injection ethanol : inclusion discuss .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>Comparison image modality</keyword>
	<keyword>predict effectiveness neoadjuvant chemotherapy</keyword>
</DOC>